RhumbLine Advisers’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-333,936
Closed -$6.97M 3077
2022
Q3
$6.97M Buy
333,936
+14,616
+5% +$304K 0.01% 1073
2022
Q2
$6.63M Buy
319,320
+17,428
+6% +$310K 0.01% 1104
2022
Q1
$5.07M Sell
301,892
-3,694
-1% -$64.6K 0.01% 1303
2021
Q4
$6.1M Buy
305,586
+10,867
+4% +$205K 0.01% 1254
2021
Q3
$5.35M Sell
294,719
-32,769
-10% -$751K 0.01% 1326
2021
Q2
$8.84M Sell
327,488
-31,713
-9% -$887K 0.01% 1087
2021
Q1
$10.8M Sell
359,201
-1,396
-0.4% -$47.6K 0.01% 945
2020
Q4
$10.4M Buy
360,597
+56,034
+18% +$1.51M 0.01% 898
2020
Q3
$7.43M Sell
304,563
-18,425
-6% -$397K 0.01% 924
2020
Q2
$5.78M Buy
322,988
+46,615
+17% +$613K 0.01% 1118
2020
Q1
$2.25M Buy
276,373
+26,364
+11% +$301K ﹤0.01% 1485
2019
Q4
$3.3M Buy
250,009
+12,878
+5% +$156K 0.01% 1509
2019
Q3
$2.82M Sell
237,131
-764
-0.3% -$14.1K 0.01% 1537
2019
Q2
$5.82M Buy
237,895
+27,191
+13% +$783K 0.01% 1105
2019
Q1
$6.71M Buy
+210,704
New +$7.48M 0.01% 1004

Other funds holding CVET

RhumbLine Advisers's CVET Position: Q4 2022 in Review

RhumbLine Advisers sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 333,936 shares — an estimated $6.97M sold.

RhumbLine Advisers first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $10.8M in Q1 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • RhumbLine Advisers reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 333,936 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $6.97M.
  • RhumbLine Advisers first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • RhumbLine Advisers's Covetrus, Inc. Common Stock position peaked at $10.8M in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.